Philmans Pharm,, The German Patient Roundtable

Est. 1977

20,000 German pharmacies; supply 3.6 million people daily and provide 150,000 jobs.

The laws recently decided to strengthen the medicines and technical aids can improve the care of many patients, but the pharmacies as providers currently facing serious challenges in the regulatory framework. The prohibition on mail for prescription drugs and the strengthening of drug price regulation associated one of the core concerns of pharmacists for the coming legislative term of the Bundestag. This conviction represents the chairman of the German Association of Pharmacists (DAV), Fritz Becker, in his Political Report to the opening of the 54th DAV Economic Forum in Berlin. In the pharmaceutical supply Support Act (AM-VSG) and (HHVG) in medicines and medical aids Supply Act partial success, although had been made, so Becker, but the good supply of medicines in itself is now at risk.

“That finally got the compensation will be adjusted for recipes requiring documentation and drugs, represents a recognition of our pharmaceutical services represent,” says Becker. It also’m him that it no longer intended to give exclusive contracts of insurance in the cytostatic supply. “The free Pharmacies choice – even with cytostatic drugs – is not Bookseller, but practiced patient and consumer protection.” For vaccines he was DAV-Chairman welcomed that the aids tenders now “confident that the delivery problems will fall by the tendering ban.” must take into account quality criteria and additional payments would be monitored more closely. “My fear is that not much will change for the insured in practice. Therefore, we must continue to be vigilant. Just small pharmacies “In addition, excessive documentation requirements could” to waive the provision of aids move “.

Looking at the regulatory and economic uncertainties and imponderables for pharmacies in the outgoing and next legislature Becker calls his colleagues to take decisive action on: “The year of the federal election is ready hold significant challenges for us has to face our profession and will provide – ! with confidence, unity and dedication “The DAV-chairman continued:” Let us continue to fight together for an excellent network of 20,000 pharmacies, which supplies daily 3.6 million people, produces 250,000 messenger services and provides 150,000 jobs. ”




Over the last 4 decades I have been involved in the fight for patient rights in America, and now here in Germany. During my career I have served as a Board of Director for the World Trade Center San Diego and as a Lead Consultant for Deutsche Telekom's Executive Board, Co-Founded the San Diego Software Council and the Dayton Human Trafficking Accords and was Director of LawInfo's Lead Council Program. Previously I was a C-Level Business Development Executive in the technology sector, but also involved with the cannabis industry since 1977. More recently I have been fulltime in the legal medical marijuana industry here in Europe, helping international companies navigate the biggest potential market in the world. This website is light on details due to confidentiality issues with clients but be rest assured I am knowledgeable, professional and with street cred in the industry that can immediately assist your growth in some way. Consulting Services: Sales and Business Development Assist with Strategic Direction Professionally represent your firm Special Projects management Licensing and compliance Sales and Distribution networks Qualify potential partners I am your resource on the ground in Europe, contact me directly to schedule an initial discussion on the German Cannabis-as-Medicine market. Thank you, Philip J. Cenedella IV Call +1.888.206.3264 USA + GERMANY Skype: philip.j.cenedella eMail: LinkedIN:

Comments are closed.